Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1998 1
1999 2
2000 1
2001 1
2003 2
2005 3
2006 2
2007 1
2008 3
2010 2
2011 2
2012 3
2013 5
2014 4
2015 3
2016 3
2017 8
2018 15
2019 14
2020 12
2021 23
2022 18
2023 11
2024 19
2025 15

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Results by year

Filters applied: . Clear all
Page 1
Total neoadjuvant therapy with mFOLFIRINOX versus preoperative chemoradiotherapy in patients with locally advanced rectal cancer: long-term results of the UNICANCER-PRODIGE 23 trial.
Conroy T, Castan F, Etienne PL, Rio E, Mesgouez-Nebout N, Evesque L, Vendrely V, Artignan X, Bouché O, Gargot D, Boige V, Bonichon-Lamichhane N, Louvet C, Morand C, de la Fouchardière C, Boilève A, Delaye M, Gourgou S, Pezzella V, Borg C. Conroy T, et al. Among authors: vendrely v. Ann Oncol. 2024 Oct;35(10):873-881. doi: 10.1016/j.annonc.2024.06.019. Epub 2024 Jul 8. Ann Oncol. 2024. PMID: 38986769 Free article. Clinical Trial.
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial.
Conroy T, Bosset JF, Etienne PL, Rio E, François É, Mesgouez-Nebout N, Vendrely V, Artignan X, Bouché O, Gargot D, Boige V, Bonichon-Lamichhane N, Louvet C, Morand C, de la Fouchardière C, Lamfichekh N, Juzyna B, Jouffroy-Zeller C, Rullier E, Marchal F, Gourgou S, Castan F, Borg C; Unicancer Gastrointestinal Group and Partenariat de Recherche en Oncologie Digestive (PRODIGE) Group. Conroy T, et al. Among authors: vendrely v. Lancet Oncol. 2021 May;22(5):702-715. doi: 10.1016/S1470-2045(21)00079-6. Epub 2021 Apr 13. Lancet Oncol. 2021. PMID: 33862000 Clinical Trial.
Rectal cancer radiotherapy.
Vendrely V, Rivin Del Campo E, Modesto A, Jolnerowski M, Meillan N, Chiavassa S, Serre AA, Gérard JP, Créhanges G, Huguet F, Lemanski C, Peiffert D. Vendrely V, et al. Cancer Radiother. 2022 Feb-Apr;26(1-2):272-278. doi: 10.1016/j.canrad.2021.11.002. Epub 2021 Dec 23. Cancer Radiother. 2022. PMID: 34953708
Organ preservation with chemoradiotherapy plus local excision for rectal cancer: 5-year results of the GRECCAR 2 randomised trial.
Rullier E, Vendrely V, Asselineau J, Rouanet P, Tuech JJ, Valverde A, de Chaisemartin C, Rivoire M, Trilling B, Jafari M, Portier G, Meunier B, Sieleznieff I, Bertrand M, Marchal F, Dubois A, Pocard M, Rullier A, Smith D, Frulio N, Frison E, Denost Q. Rullier E, et al. Among authors: vendrely v. Lancet Gastroenterol Hepatol. 2020 May;5(5):465-474. doi: 10.1016/S2468-1253(19)30410-8. Epub 2020 Feb 7. Lancet Gastroenterol Hepatol. 2020. PMID: 32043980 Clinical Trial.
[Radiation-induced sexual toxicity].
Besnard C, Lemanski C, Vendrely V. Besnard C, et al. Among authors: vendrely v. Cancer Radiother. 2021 Dec;25(8):816-821. doi: 10.1016/j.canrad.2021.09.007. Epub 2021 Oct 26. Cancer Radiother. 2021. PMID: 34711486 French.
[Rectal cancer: Towards personalized medicine].
Vendrely V, Benoist S. Vendrely V, et al. Cancer Radiother. 2021 Oct;25(6-7):650-654. doi: 10.1016/j.canrad.2021.06.026. Epub 2021 Jul 12. Cancer Radiother. 2021. PMID: 34266737 Review. French.
Radioresistant tumours: From identification to targeting.
Cohen-Jonathan-Moyal É, Vendrely V, Motte L, Balosso J, Thariat J. Cohen-Jonathan-Moyal É, et al. Among authors: vendrely v. Cancer Radiother. 2020 Oct;24(6-7):699-705. doi: 10.1016/j.canrad.2020.05.005. Epub 2020 Aug 1. Cancer Radiother. 2020. PMID: 32753241 Review.
[Restatment. Anal Cancer].
Vendrely V. Vendrely V. Rev Prat. 2021 Sep;71(7):759-763. Rev Prat. 2021. PMID: 34792915 French.
151 results